Merkoša sitáhtat
APA-čujuhus (7. p.)
Institute of Medicine (U.S.). Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, Institute of Medicine (U.S.). Board on Health Sciences Policy, National Academies Press (U.S.), ebrary, Inc, Micheel, C., Nass, S. J., & Omenn, G. S. (2012). Evolution of translational omics: Lessons learned and the path forward. National Academies Press.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Institute of Medicine (U.S.). Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, Institute of Medicine (U.S.). Board on Health Sciences Policy, National Academies Press (U.S.), Inc ebrary, Christine Micheel, Sharyl J. Nass, juo Gilbert S. Omenn. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, D.C.: National Academies Press, 2012.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Institute of Medicine (U.S.). Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, et al. Evolution of Translational Omics: Lessons Learned and the Path Forward. National Academies Press, 2012.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.